The Xpanding Innovative Alliance (XiA) is pleased to announce the establishment of its Advisory Board, marking an important step in supporting the project’s mission: equipping Europe’s healthcare ecosystem with the skills and knowledge needed to implement advanced interoperability standards as part of the European Health Data Space (EHDS).
A structured, two-level Advisory Board
To ensure both strategic guidance and operational flexibility, the XiA Advisory Board is structured around two complementary levels:
- Main Advisory Board (AB): A core group of selected experts providing strategic and scientific direction, ensuring alignment with real-world needs across interoperability, education, and digital health policy.
- Individual Technical Advisors (ITAs): Specialists available for targeted consultations on specific technical or educational topics.
After a thorough selection process — with 57 nominations received from across Europe — XiA has built a diverse and representative body, bringing together expertise from international organizations, academia, and digital health networks.
We are also pleased to confirm that Professor Philip Scott, University of Wales Trinity Saint David (UWTSD) has been appointed as Chair of the Advisory Board. In this role, he will coordinate activities, facilitate communication between members, and act as the main liaison with the ITAs.
Members of the XiA Advisory Board
The XiA Advisory Board brings together experts from various sectors and countries, contributing to the project’s scientific and strategic direction:
- Professor Philip Scott, University of Wales Trinity Saint David (UWTSD), United Kingdom – Chair
- Lars Lindskold, European Federation for Medical Informatics (EFMI), Sweden
- Sari Palojoki, Ministry of Social Affairs and Health care, Finland
- Daiana Huber, Center for promoting lifelong learning Romania / University of Timisoara, Romania
- Crina Damsa, University of Oslo, Norway
- Matthias Löbe, IMISE U Leipzig, Germany
- Michael Johansen, MedCom, Denmark
- Elia Lima-Walton, Mayo Clinic, United States
- Anju Philip, Roche Diagnostics GmbH, Germany
- Sudipto Das, Royal College of Surgeons in Ireland (RCSI) – University of Medicine and Health Sciences, Ireland
Why it matters?
The Advisory Board’s mission is to actively shape XiA’s training offer and strategic direction. By sharing insights, reviewing content, and ensuring stakeholder alignment, its members play a central role in making XiA a useful, credible, and future-proofed resource for healthcare professionals and digital health actors across Europe.
Regular online meetings will be held at least twice a year to maintain a dynamic, responsive dialogue between the consortium and its Advisory Board.